Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Sustainability Reports

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. develops, manufactures, and markets biopharmaceutical products in China. Its offerings primarily focus on photodynamic technology drugs, anti-tumor treatments, and genetic engineering drugs.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

FIGI: BBG001SJW0P2

16 reports from 2006 to 2025

• Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 2025 Environmental, Social and Governance Report
• Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 2024 Annual Report
• Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 2024 Environmental, Social and Governance Report
• Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 2023 Environmental, Social and Governance Report
• Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 2022 Annual Report